Penicillin Market by Type and Geography - Forecast and Analysis 2020-2024

The penicillin market size has the potential to grow by USD 1.65 billion during 2020-2024, and the market's growth momentum will accelerate during the forecast period because of the steady increase in year-over-year growth.

This report provides a detailed analysis of the market by type (oral and parenteral) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market's competitive landscape. It offers information on several market vendors, including Astellas Pharma Inc., Biocon Ltd., Cadila Healthcare Ltd., GlaxoSmithKline Plc, Merck & Co. Inc., Mylan NV, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.

Market Overview

Browse TOC and LoE with selected illustrations and example pages of Penicillin Market

Request a FREE sample now!

Market Competitive Analysis

The penicillin market is fragmented with the presence of both large and small-sized players that are offering both branded and generic drugs to cater to the growing demand from people with bacterial infections. Astellas Pharma Inc., Biocon Ltd., and Cadila Healthcare Ltd. are some of the major market participants. Although the significant comorbidity associated with bacterial infections will offer immense growth opportunities, the use of alternative therapies will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this penicillin market forecast report provides a detailed analysis of the market leaders. It offers information on the competencies and capacities of these companies. The report also covers details on the market's competitive landscape and provides information on the products offered by various companies. Moreover, this penicillin market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading companies, including:

• Astellas Pharma, Inc.
• Biocon Ltd.
• Cadila Healthcare Ltd.
• GlaxoSmithKline Plc
• Merck & Co., Inc.
• Mylan NV
• Pfizer Inc.
• Sanofi
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

Penicillin Market: Segmentation by Type

Request for a FREE sample and Get more information on the market contribution of various segments

The ease of administration of oral penicillin antibiotics, as well as their lower price when compared with parenteral penicillin antibiotic are some of the significant factors driving the oral market segment of the penicillin market.

The penicillin market share growth by the oral segment will be faster than the growth of the market by the parenteral segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the penicillin market size.

Penicillin Market: Segmentation by Geography

For more insights on the market share of various regions Request for a FREE sample now!

North America was the largest penicillin market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The increased investments in R&D and the presence of a proper regulatory framework for the approval of new drugs are some of the factors that will significantly influence bone cement market growth in this region.

Almost 33% of the market's growth will originate from North America during the forecast period. The US, Canada, and Mexico is the key market for penicillin in North America. Market growth in this region will be faster than the growth of the market in other regions.

Penicillin Market: Key Drivers and Trends

All types of bacterial infections are associated with various chronic symptoms, such as fever, muscle fatigue, headache, nausea, vomiting, and swollen lymph nodes in the neck, armpits, or groin, which are persistently disturbing and cause a negative impact on patients? lives. To avoid the significant comorbidity associated with bacterial infections, people spend on the required therapeutic regimen, comprising penicillin, which is driving the growth of the market in focus. The availability of advanced diagnostic methods, such as serological cross-reactivity, is also driving sales of antibiotics such as penicillin. Advanced diagnostic methods have helped in the identification of pathogens as a possible cause of common bacterial infections.

• Infectious diseases continue to have significant health and economic costs, particularly in developing countries such as India and China. The treatment cost for infectious diseases can lead patients and their families into poverty, undermine the resilience of communities, thus presenting a major threat to the country's economy.
• Several public and private organizations are focusing on providing quality health services to people at low costs.
• The universal health coverage (UHC), a public health management program run by the World Health Organization, is making efforts to expand access to health services and coverage of critical interventions over the past two decades.
• The increasing efforts of organizations to overcome the high financial burden of people and to increase the accessibility and affordability of medicines is one of the vital penicillin market trends.
• The market is expected to record a CAGR of over 4% during the forecast period.

Request for a FREE sample

Penicillin Market: Key Highlights of the Report for 2020-2024

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will drive penicillin market growth during the next five years
• Precise estimation of the penicillin market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the penicillin industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of penicillin market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch